These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 868904)

  • 1. Nosocomial bloodstream infections caused by gentamicin-resistant gram-negative bacilli.
    Guerrant RL; Strausbaugh LJ; Wenzel RP; Hamory BH; Sande MA
    Am J Med; 1977 Jun; 62(6):894-901. PubMed ID: 868904
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
    Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
    Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amikacin treatment of pulmonary infections involving gentamicin-resistant gram-negative bacilli.
    Bartlett JG
    Am J Med; 1977 Jun; 62(6):945-8. PubMed ID: 868911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR; Greenman RL; Hoffman TA
    Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amikacin therapy of severe infections produced by gram-negative bacilli resistant to gentamicin.
    Valdivieso M; Bodey GP
    Am J Med Sci; 1977; 273(2):177-84. PubMed ID: 860733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms.
    Weinstein RA; Nathan C; Gruensfelder R; Kabins SA
    J Infect Dis; 1980 Mar; 141(3):338-45. PubMed ID: 6767795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nosocomial catheter-related sepsis secondary to central venous catheters].
    Wu H; Wu Z; Jin D; Xu J
    Zhonghua Wai Ke Za Zhi; 1999 Nov; 37(11):651-3. PubMed ID: 11829916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A
    Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of 152 patients with bacteremias treated with amikacin.
    Tally FP; Gorbach SL
    Am J Med; 1977 Jun; 62(6):940-4. PubMed ID: 868910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
    Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
    Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of genes for trimethoprim and gentamicin resistance in bacteria and their plasmids in a general hospital.
    Datta N; Dacey S; Hughes V; Knight S; Richards H; Williams G; Casewell M; Shannon KP
    J Gen Microbiol; 1980 Jun; 118(2):495-508. PubMed ID: 7003059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms.
    Tally FP; Louie TJ; Weinstein WM; Bartlett JG; Gorbach SL
    Ann Intern Med; 1975 Oct; 83(4):484-8. PubMed ID: 1101761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial infections due to gram-negative bacilli in compromised hosts: considerations for prevention and therapy.
    Klastersky J
    Rev Infect Dis; 1985; 7 Suppl 4():S552-8. PubMed ID: 3909312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gram-negative bacteremias. Analysis of factors for clinical assessment of gentamicin resistance.
    Lynch JM; Hodges GR; Clark GM; Dworzack DL
    Arch Intern Med; 1981 Apr; 141(5):582-6. PubMed ID: 7224738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with aztreonam in the treatment of gram-negative bacteremia.
    Scully BE; Henry SA
    Rev Infect Dis; 1985; 7 Suppl 4():S789-93. PubMed ID: 3909338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin therapy for gram-negative septicemia.
    Meyer RD; Lewis RP; Finegold SM
    Am J Med; 1977 Jun; 62(6):930-5. PubMed ID: 868908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amikacin.
    Gleckman R
    Am Fam Physician; 1976 Dec; 14(6):75. PubMed ID: 998471
    [No Abstract]   [Full Text] [Related]  

  • 19. Amikacin therapy for severe gram-negative sepsis: efficacy in infections involving gentamicin-resistant organisms.
    Tally FP; Louie TJ; O'Keefe P; Gorbach SL; Bartlett JG
    J Infect Dis; 1976 Nov; 134 SUPPL():S428-32. PubMed ID: 993634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amikacin therapy of gram-negative bacteremia.
    Tally FP; Gorbach SL
    Am J Med; 1977 Jun; 62(6):936-9. PubMed ID: 868909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.